Genesis Showcases Pipeline at ALDM 2024 in Chicago

In the global landscape of biotechnology and medical diagnostics, Hangzhou Genesis Biodetection and Biocontrol Co., Ltd. has emerged as an important player. As a testament to its commitment to excellence and international outreach, the company is set to participate in the prestigious Association for Diagnostics & Laboratory Medicine (ALDM) Exhibition 2024, showcasing its latest products and promoting the Genesis brand on a global stage.

About Genesis: A Brief Introduction

Founded in 2002 in the vibrant Hangzhou Economic and Technological Development Zone, Hangzhou Genesis is a joint venture born from the collaboration between leading bio-diagnostic reagent companies in Japan and the United States, and supported by experienced domestic investors. With an expansive facility spanning 15,000 square meters, the company has established itself as a pioneering force in the field of in vitro diagnostic (IVD) reagents.

Over the years, Hangzhou Genesis has cultivated a reputation for excellence, leveraging advanced experimental techniques, sophisticated instrumentation, and a profound understanding of the industry. Its dedication to delivering high-quality medical diagnostic products and specialized technical services has earned it widespread recognition both domestically and internationally.